📰 Steven Petrou News
Steven Petrou News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Steven Petrou. Real-time updates on events, politics, business and more.
November 28, 2022
28.11.2022 - BOSTON, Nov. 28, 2022 (GLOBE NEWSWIRE) - Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders ... Seite 1
September 20, 2022
/PRNewswire/ -- Invitae (NYSE: NVTA) and Praxis Precision Medicines, Inc. (NASDAQ: PRAX), today announced that real-world clinical insights from Invitaes...
September 20, 2022
20.09.2022 - First use of Ciitizen platform as source of real-world data in regulatory filingSAN FRANCISCO and BOSTON, Sept. 20, 2022 (GLOBE NEWSWIRE) - Invitae (NYSE: NVTA) and Praxis Precision Medicines, Inc. (NASDAQ: PRAX), today announced that real-world ... Seite 1
March 1, 2022
PRAX-114 Phase 2/3 monotherapy MDD Aria Study topline results expected in June 2022
December 4, 2021
GlaxoSmithKline poached Pfizer's RNA and viral vaccines leader Phil Dormitzer, M.D., Ph.D., to shore up its vaccine business as it's lost many research staffers this past year. Parthenon Therapeutics snagged Johnson & Johnson's global head of cell therapy platform and discovery, Tamas Oravecz, Ph.D. And Rafael parted ways with five execs and reinstalled telecom tycoon Howard Jonas as CEO.